KYSA-8: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Treatment Refractory Stiff Person Syndrome
Clinical trial NCT06588491 · COMPLETED
Trial details
- NCT number
- NCT06588491
- Sponsor
- Kyverna Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-25
- Primary completion
- 2026-06-25
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.